Therefore, activating GLP-1R in fibroblasts could antagonize macrophage-derived signal-triggered fibroblast activation by inhibiting NLRP3 inflammasome activation, PFKFB3-driven glycolysis and histone lactylation
In terms of tolerability, tirzepatide generally causes fewer gastrointestinal side effects, making it a better option for those sensitive to nausea, while Semaglutide GLP-1 may cause mild to moderate gastrointestinal issues like nausea and diarrhea, which usually subside over time
Most patients are able to continue treatment
Cells were lysed with RIPA buffer (Astral Scientific, Sydney, Australia) and total DNA quantified using Quanti-iT PicoGreen (Life Technologies, Gaithersburg, MD, USA)
Many insurance plans do cover GLP-1 medications for the treatment of type 2 diabetes and obesity, but coverage may be limited for certain medications or patient populations
The only requirement is an assessment of renal function before initiating therapy, and periodical check-ups thereafter are recommended (Figure 3)